Immunitybio Inc. Earnings

Immunitybio Inc.’s revenue jumped 7346.34% since last year same period to $6.11Mn in the Q3 2024. On a quarterly growth basis, Immunitybio Inc. has generated 483.19% jump in its revenue since last 3-months.

Immunitybio Inc.’s net profit jumped 10.31% since last year same period to $-85.73Mn in the Q3 2024. On a quarterly growth basis, Immunitybio Inc. has generated 36.29% jump in its net profits since last 3-months.

Immunitybio Inc.’s net profit margin jumped 98.8% since last year same period to -1404.01% in the Q3 2024. On a quarterly growth basis, Immunitybio Inc. has generated 89.08% jump in its net profit margins since last 3-months.

Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a -23.08% fall from last quarter’s estimates.

Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.16.

Immunitybio Inc.’s earning per share (EPS) jumped 77.14% since last year same period to -0.08 in the Q4 2024. This indicates that the Immunitybio Inc. has generated 77.14% annual rate of jump in its earning per share (EPS) in the last 4 quarters.